PMID- 29499127 OWN - NLM STAT- MEDLINE DCOM- 20181211 LR - 20220331 IS - 1097-6779 (Electronic) IS - 0016-5107 (Linking) VI - 88 IP - 1 DP - 2018 Jul TI - Submucosal tunnel endoscopic resection for extraluminal tumors: a novel endoscopic method for en bloc resection of predominant extraluminal growing subepithelial tumors or extra-gastrointestinal tumors (with videos). PG - 160-167 LID - S0016-5107(18)30146-9 [pii] LID - 10.1016/j.gie.2018.02.032 [doi] AB - BACKGROUND AND AIMS: The management of subepithelial tumors with a predominant extraluminal growth pattern or extra-GI tumors can be challenging and traditionally requires a surgical resection that is not only invasive but may carry a significant risk of morbidity and mortality. We aimed to assess the feasibility, safety, and efficacy of a novel endoscopic technique termed submucosal tunnel endoscopic resection for extraluminal tumors (STER-ET). METHODS: We prospectively enrolled patients who underwent STER-ET for GI subepithelial tumors with a predominant extraluminal growth pattern or extra-GI tumors located at the level of cardia or the proximal part of the lesser curvature of the stomach seen on cross-sectional imaging between January 2016 and March 2017. RESULTS: Eight patients underwent STER-ET. The mean (+/- standard deviation) tumor size was 2.8 +/- 0.6 cm and 2.3 +/- 0.8 cm in longest and shortest dimension, respectively. The average procedure time was 67 +/- 4.4 minutes. The rates of curative en bloc resection and en bloc retrieval was 100% and 87.5%, respectively. On final histology, 6 tumors were GI stromal tumors, 1 was a schwannoma, and 1 was a foregut cyst. Five patients had capnoperitoneum during the procedure and required abdominal decompression. One patient had a small mucosotomy successfully treated with a hemostatic clip. There were no major adverse events or deaths. The median length of hospital stay was 3 days. There was no residual tumor on surveillance imaging after a mean follow-up period of 10.0 +/- 2.1 months. CONCLUSIONS: STER-ET is a novel technique that appears to be safe and effective in achieving a curative resection for GI subepithelial tumors with a predominantly extraluminal growth pattern or extraluminal tumors in a selected group of patients. However, larger studies are required to validate our finding. CI - Copyright (c) 2018 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. FAU - Cai, Ming-Yan AU - Cai MY AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Zhu, Bo-Qun AU - Zhu BQ AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Xu, Mei-Dong AU - Xu MD AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Qin, Wen-Zheng AU - Qin WZ AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Zhang, Yi-Qun AU - Zhang YQ AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Chen, Wei-Feng AU - Chen WF AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Ooi, Marie AU - Ooi M AD - Department of Gastroenterology, Royal Adelaide Hospital, South Adelaide, Australia. FAU - Li, Quan-Lin AU - Li QL AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Yao, Li-Qing AU - Yao LQ AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Zhou, Ping-Hong AU - Zhou PH AD - Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. LA - eng PT - Journal Article PT - Video-Audio Media DEP - 20180227 PL - United States TA - Gastrointest Endosc JT - Gastrointestinal endoscopy JID - 0010505 SB - IM MH - Aged MH - Cysts/diagnostic imaging/pathology/*surgery MH - Endoscopic Mucosal Resection/*methods MH - Endoscopy, Digestive System/*methods MH - Esophagogastric Junction/diagnostic imaging/pathology/*surgery MH - Female MH - Gastrointestinal Stromal Tumors/diagnostic imaging/pathology/*surgery MH - Humans MH - Male MH - Middle Aged MH - Neurilemmoma/diagnostic imaging/pathology/*surgery MH - Prospective Studies MH - Stomach Neoplasms/diagnostic imaging/pathology/*surgery MH - Tomography, X-Ray Computed MH - Tumor Burden EDAT- 2018/03/03 06:00 MHDA- 2018/12/12 06:00 CRDT- 2018/03/03 06:00 PHST- 2017/10/31 00:00 [received] PHST- 2018/02/20 00:00 [accepted] PHST- 2018/03/03 06:00 [pubmed] PHST- 2018/12/12 06:00 [medline] PHST- 2018/03/03 06:00 [entrez] AID - S0016-5107(18)30146-9 [pii] AID - 10.1016/j.gie.2018.02.032 [doi] PST - ppublish SO - Gastrointest Endosc. 2018 Jul;88(1):160-167. doi: 10.1016/j.gie.2018.02.032. Epub 2018 Feb 27.